FT : The private market “supercycle”

The private market “supercycle”
Goldman Sachs reckons that the boom in private capital has much, much further to run.

The hottest thing in finance is not passive funds, crypto or even commodities. It is private capital — things like venture capital, infrastructure, private equity and direct lending — and it is absolutely booming.

Last year, the overall size of the private capital industry rose to over $10tn, and industry data provider Preqin predicted that this will grow to almost $18bn by 2026. However, Goldman Sachs forecasts that it could actually swell to as big as $30tn by then, if it continues to make retail investor inroads and interest rates don’t go up as much as feared.

We believe future industry AUM growth dynamics of private markets will be driven by seven key factors over the medium term, including track record vs. public markets, interest rates, and the retail opportunity, among others. Assessing each of these factors in this report, we see an overall positive backdrop for industry AUM growth to continue. Moreover, we combine this 7-point framework with Preqin’s 2026 industry AUM forecast of $17.8tn and through-cycle growth since 2000 to assess the potential pathways over the next 5Y, including a blue-sky $30tn+ scenario for private markets (ie >3x from today).

Here are the relevant Goldman charts showing that upside scenario.


Now, one should always take sellside Big Numbers with a pinch of salt. Goldman Sachs stresses that this is its “blue sky” forecast. Its “grey sky” prediction is for more moderate industry size of just under $15tn by 2026, as rising interest rates and limp retail demand weigh on growth.

In a grey-sky scenario, we see scope for the growth profile of private markets AUM to reflect the one achieved between 2008 and 2012, rising at a blended CAGR of c. 8% (which is within one standard deviation of the long-term average). This scenario would result in 2026 industry AUM of US$14.8tn, which is c. 20% smaller than our base case. We believe a bearish view on industry AUM growth could be driven by a faster-than-anticipated hike in interest rates to higher levels vs. historical averages (such as if inflation were to continue rising due to wage pressure and geopolitical factors), regulatory headwinds constraining further institutional investment from pensions and endowments, a lack of retail investment in private markets, and a failure to close the gap between current and target allocations.

And here are the charts for how that scenario would shake out:

However, the fact that Goldman Sachs expects private capital to jump to almost $15tn in less than five years even in its gloomy scenario underscores just how mental things are in the space right now.

This is why there has been a mad dash by pretty much every big traditional asset manager to snap up private capital specialists in recent years, whether they operate in racier areas like private debt or less-glamorous infrastructure.

Off the top of Alphaville’s head, just the most recent (ish) deals are — deep breath — Schroders buying Greencoat and Cairn Real Estate; AllianceBernstein buying CarVal Investors; Franklin Templeton buying Lexington Partners, Benefit Street Partners and Clarion Partners; T Rowe Price buying Oak Hill; and JPMorgan Asset Management buying Campbell Global.

There are many we have forgotten, and there are undoubtedly more coming in what looks like a private capital gold rush. Anyway, for afficionados of sellside graphics, here is Goldman’s seven-factor framework for private capital.

>>> US Research Calls

Research Calls

  • Upgrades:
    • Aptiv (APTV) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $112
    • Brighthouse Financial (BHF) upgraded to Equal Weight from Underweight at Wells Fargo; tgt raised to $54
    • Cardinal Health (CAH) upgraded to Overweight from Equal-Weight at Morgan Stanley; tgt $74
    • Charles Schwab (SCHW) upgraded to Buy from Neutral at Compass Point; tgt $98
    • CrowdStrike (CRWD) upgraded to Buy from Neutral at Goldman; tgt raised to $285
    • Domino's Pizza (DPZ) upgraded to Buy from Neutral at Citigroup; tgt raised to $487
    • Ferrari (RACE) upgraded to Outperform from Neutral at Exane BNP Paribas
    • Finmeccanica SpA (FINMY) upgraded to Buy from Hold at Deutsche Bank
    • First Financial (THFF) upgraded to Outperform from Mkt Perform at Raymond James; tgt $49
    • ICON plc (ICLR) upgraded to Buy from Hold at Deutsche Bank; tgt raised to $310
    • Juniper Networks (JNPR) upgraded to Neutral from Sell at Citigroup; tgt raised to $36
    • Louisiana-Pacific (LPX) upgraded to Buy from Hold at TD Securities; tgt $75
    • Novo Nordisk A/S (NVO) upgraded to Equal-Weight from Underweight at Morgan Stanley
    • Ryanair Hldgs (RYAAY) upgraded to Buy from Neutral at UBS
  • Downgrades:
    • AmerisourceBergen (ABC) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt $178
    • Bancolombia S.A. (CIB) downgraded to Neutral from Overweight at JP Morgan; tgt $46
    • Chegg (CHGG) downgraded to Sector Weight from Overweight at KeyBanc Capital Markets
    • Cisco (CSCO) downgraded to Sell from Neutral at Citigroup; tgt lowered to $45
    • Dana Inc (DAN) downgraded to Equal Weight from Overweight at Wells Fargo; tgt lowered to $17
    • Enjoy Technology (ENJY) downgraded to Market Perform from Outperform at Telsey Advisory Group; tgt lowered to $4
    • F5 Networks (FFIV) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $250 and removed as Top Pick
    • Federated Hermes (FHI) downgraded to Sell from Neutral at Citigroup; tgt lowered to $28.50
    • Fiserv (FISV) downgraded to Market Perform from Outperform at Cowen; tgt lowered to $126
    • Hewlett Packard Enterprise (HPE) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $15
    • Ingredion (INGR) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $94
    • Invesco (IVZ) downgraded to Mkt Perform from Outperform at Keefe Bruyette; tgt $25
    • Krispy Kreme, Inc. (DNUT) downgraded to Neutral from Buy at Citigroup; tgt lowered to $16
    • Landos Biopharma (LABP) downgraded to Hold from Buy at Jefferies; tgt lowered to $1.40
    • NetApp (NTAP) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt lowered to $91
    • Rapid7 (RPD) downgraded to Neutral from Buy at Goldman; tgt $130
    • Repare Therapeutics (RPTX) downgraded to Hold from Buy at Stifel; tgt $11
    • Rolls Royce PLC (RYCEY) downgraded to Underweight from Neutral at JP Morgan
    • Starbucks (SBUX) downgraded to Neutral from Buy at Citigroup; tgt lowered to $91
    • STMicroelectronics (STM) downgraded to Equal Weight from Overweight at Barclays
    • Utz Brands (UTZ) downgraded to Neutral from Outperform at Credit Suisse; tgt lowered to $16.50
    • Verint Systems (VRNT) downgraded to Neutral from Buy at Goldman; tgt $57
    • Waste Mgmt (WM) downgraded to Market Perform from Outperform at BMO Capital Markets; tgt $174
  • Others:
    • ADTRAN (ADTN) initiated with a Buy at Rosenblatt; tgt $25
    • BJ Restaurants (BJRI) initiated with a Neutral at Citigroup; tgt $29
    • Bloomin' Brands (BLMN) initiated with a Neutral at Citigroup; tgt $24
    • Calian Group (CLNFF) initiated with an Outperform at BMO Capital Markets
    • Calix Networks (CALX) initiated with a Buy at Rosenblatt; tgt $60
    • Cheesecake Factory (CAKE) initiated with a Buy at Citigroup; tgt $52
    • Cracker Barrel (CBRL) initiated with a Sell at Citigroup; tgt $97
    • Darden Restaurants (DRI) initiated with a Buy at Citigroup; tgt $162
    • Denny's (DENN) initiated with a Neutral at Citigroup; tgt $15
    • First Bancorp (FBP) assumed with an Outperform at Keefe Bruyette; tgt $17.50
    • First Watch Restaurant Group (FWRG) assumed with a Buy at Citigroup; tgt lowered to $17
    • HashiCorp (HCP) initiated with a Neutral at Piper Sandler; tgt $59
    • Helmerich & Payne (HP) initiated with a Buy at The Benchmark Company; tgt $53
    • Mondelez Int'l (MDLZ) resumed with an Outperform at Credit Suisse; tgt $70
    • OFG Bancorp (OFG) assumed with an Outperform at Keefe Bruyette; tgt $35
    • Patrick Industries (PATK) initiated with a Buy at Truist; tgt $75
    • Ping Identity (PING) initiated with a Buy at DA Davidson
    • Pool (POOL) initiated with a Hold at Edward Jones
    • Popular (BPOP) assumed with an Outperform at Keefe Bruyette; tgt $115
    • Pyxis Tankers (PXS) initiated with a Buy at H.C. Wainwright; tgt $1.50
    • QuantumScape Corporation (QS) initiated with a Hold at Deutsche Bank; tgt $20
    • Sweetgreen (SG) initiated with a Neutral at Citigroup; tgt $32
    • Syneos Health (SYNH) initiated with a Buy at Deutsche Bank; tgt $102
    • Tenable (TENB) initiated with a Buy at DA Davidson; tgt $75
    • Texas Roadhouse (TXRH) initiated with a Buy at Citigroup; tgt $105
    • TORM plc (TRMD) initiated with a Buy at H.C. Wainwright; tgt $14
    • Veritone (VERI) initiated with a Neutral at UBS; tgt $18
    • Wendy's (WEN) initiated with a Neutral at Citigroup; tgt $23
    • Wingstop (WING) initiated with a Buy at Citigroup; tgt $160
    • Xometry (XMTR) initiated with a Buy at Loop Capital; tgt $50
    • Yum! Brands (YUM) initiated with a Buy at Citigroup; tgt $156

>>> US Gapping down

Gapping down
In reaction to earnings/guidance
:

  • MIMO -3.8%, ACI -3.7%, KMX -2.7%, GOL -1.4%

Other news:

  • MYOV -20.8% (Myovant Sciences and and Pfizer (PFE) provide update on sNDA for MYFEMBREE)
  • WULF -9.1% (stock offering)
  • RPTX -4.9% (presents updated data from ongoing Phase 1/2 TRESR study)
  • VMEO -3.3% (reports monthly metrics for March)
  • ENSG -3.2% (receives new $600 million credit facility)
  • LFLY -0.9% (stock offering)
  • BEN -0.8% (reports March AUM)

Analyst comments:

  • ENJY -4.7% (downgraded to Market Perform from Outperform at Telsey Advisory Group)
  • CHGG -3.7% (downgraded to Sector Weight from Overweight at KeyBanc Capital Markets)
  • HPE -3.4% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
  • DAN -2.8% (downgraded to Equal Weight from Overweight at Wells Fargo)
  • CSCO -2.5% (downgraded to Sell from Neutral at Citigroup)
  • FHI -2.3% (downgraded to Sell from Neutral at Citigroup)
  • FFIV -1.6% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • DNUT -1.5% (downgraded to Neutral from Buy at Citigroup)
  • ABC -1.2% (downgraded to Equal-Weight from Overweight at Morgan Stanley)
  • FISV -1.1% (downgraded to Market Perform from Outperform at Cowen)

>>> US Gapping up

Gapping up

News:

  • ATNM +27.8% (Actinum Pharma and Immedica to commercialize Iomab-B (131I apamistamab) in Europe the Middle East and North Africa)
  • AGLE +17.7% (presents additional data from PEACE phase 3 study of Pegzilarginase; submits BLA to FDA for Pegzilarginase)
  • SPNE +5% (announces full commercial launch of Reef TA Interbody System)
  • GDYN +5% (expands in Europe ceases operations in Russia)
  • APAM +4.7% (reports March AUM)
  • VTGN +3.8% (VistaGen and AffaMed Complete Key Regulatory Submissions for PALISADE Global Phase 3 Clinical Trial for PH94B)
  • CVAC +1.6% (CureVac and GSK Enter into pandemic preparedness contract with German Government)
  • GROY +1.2% (provides update on Elemental offer)
  • EWCZ +1.1% (declares special dividend of $3.30 per share)
  • TAK +0.9% (Phase 3 SHP643-301 study (NCT04070326) evaluating the safety profile and pharmacokinetics of TAKHZYRO in patients 2 to <12 years of age met its objectives)

Analyst comments:

  • CRWD +3.6% (upgraded to Buy from Neutral at Goldman)
  • CAH +2.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
  • DPZ +0.9% (upgraded to Buy from Neutral at Citigroup)

>>> US Early premarket gappers

Early premarket gappers

  • Gapping up:
    • AGLE +32.1%, SPNE +5%, GDYN +5%, CVAC +2.3%, APAM +2.1%, GROY +1.2%, EWCZ +1.1%
  • Gapping down:
    • MYOV -9.2%, WULF -9.1%, ENSG -6.4%, VMEO -3.3%, GOL -1.4%, LFLY -0.9%, RKLB -0.8%, ZNTL -0.5%

JDD - Gaspard Proust : McKinsey, milice Wagner du cost-killing

JDD - Gaspard Proust : McKinsey, milice Wagner du cost-killing

Mais qu’est-ce qui motive tant un homme politique à vouloir devenir locataire del’Élysée ?
La réponse est simple : un service de conciergerie hors norme. Un problème à n’importe quelle heure de la journée ? Pas de panique, à l’autre bout du fil, un conseiller McKinsey est là pour vous guider. Mais attention, on ne parle pas d’une conciergerie lambda, non, ici, c’est le domaine de l’über-luxe. Attendre un conseiller au téléphone est susceptible
de vous coûter 300 balles la seconde du Printemps de Vivaldi. Un peu comme chez Mozart où le silence après du
Mozart, c’est encore du Mozart ; chez McKinsey, le silence avant le bullshit, c’est déjà du bullshit.

Des mauvaises langues vont nous expliquer qu’on pourrait faire en interne ce qu’on externalise. C’est évidemment débile. Ce qu’on paie dans un cabinet de conseil, ce n’est pas tant l’expertise (les types qui bossent chez McKinsey ont
fait les mêmes écoles que ceux qui les recrutent — je mets bien sûr Christophe Castaner et Marlène Schiappa à part),
mais comme les mesures à prendre sont rarement faciles à assumer, le cabinet sert à un transfert de responsabilité ; ce que j’appellerai pudiquement la délocalisation de la couille.

Vouloir faire faire le boulot de McKinsey par des fonctionnaires consisterait à leur dire : « Hé, les gars, pondez-nous un truc qui démontrera que vous êtes trop nombreux et trop chers ! »

En coaching, c’est un peu comme tenter de remobiliser le PSG à la mi-temps en envoyant Domenech dans les vestiaires. Il faut comprendre : quand ta propre armée est démobilisée, tu appelles les mercenaires. C’est là qu’intervient McKinsey, notre milice Wagner du cost-killing. Mais au lieu de les juger, mettons nous un instant à la place de ces gens :
enchaîner classes prépa, concours, grandes écoles, tout ça pour finir en brainstorming sur un montant d’APL… Imagine-t-on Nadal donner des cours de tennis dans un Club Med ?

Il faut imaginer le chemin de Damas intérieur de ces têtes bien faites à qui le chef d’équipe a dû dire pour éviter les
suicides : « Relax les gars, le mot APL c’est juste un nom de code pour désigner les taux de la Fed. En réalité, vous êtes en train de bosser pour Jerome Powell ! »

De manière plus personnelle, je me souviens encore avec émotion de la présentation de McKinsey à l’époque où je n’étais encore qu’un anonyme petit branleur à HEC Lausanne. C’étaient les seuls à venir en disant : « Bonjour,
ne vous emballez pas, on vient juste vous faire l’honneur de vous distribuer notre plaquette, on commencera à étudier votre cas une fois que vous aurez complété votre cursus par un MBA à Harvard, un postgrade en physique quantique à Stanford, un premier prix de violon, une sélection pour les JO et si en plus vous avez fondé une ONG au Vietnam durant votre tour du monde en trottinette solaire, c’est un plus.

Un cost-killer, c’est bien, mais un cost-killer qui sait sourire à un enfant cul-de-jatte ayant joué à la marelle dans un champ de mines, c’est mieux. » À les écouter, je l’avoue, je rêvais moi aussi d’en être. D’être ce puceau endimanché qui présenterait des PowerPoint facturés au prix d’esquisses de Picasso à un parterre de PDG qui boiraient mes paroles comme si je venais de leur offrir un week-end « putes et casino » à Monaco.

Je me souviens des collègues qui ont fini dans ces boîtes. En général, c’étaient les indécis. « Tu vas faire quoi après ?
Finance ou marketing ?… Je sais pas… Ah, ok, donc du conseil ! » C’est normal.

Dans la vie, ceux qui conseillent sont rarement ceux qui font. Ce sont d’abord et avant tout des entrepreneurs du risque des autres. Il suffit de comparer le chiffre d’affaires de la boîte d’Alain Minc avec celui de LVMH. Respectueusement. g


FT : UK accounting regulator investigates Deloitte over Go-Ahead audits

UK accounting regulator investigates Deloitte over Go-Ahead audits
Bus and rail operator's shares were temporarily suspended in January after it missed deadline for filing results

Deloitte is under investigation by the UK accounting regulator over its audits of bus and rail operator Go-Ahead Group.

The Financial Reporting Council said on Tuesday that it was probing the Big Four auditor’s checks on Go-Ahead’s accounts for the six financial years ended between June 2016 and July 2021.

The regulator did not disclose the focus of its investigation, which it said was launched on March 22. The investigation would not relate to any individuals other than the statutory auditors who signed off the accounts in the relevant years, it said.

Go-Ahead’s shares were suspended from trading on the London Stock Exchange in January this year because it was unable to publish its financial results within the time allowed under market rules. The results were eventually published on February 24.

Deloitte said it would co-operate fully with the FRC’s investigation and was “committed to the highest standards of audit quality”.

>>> Europe : Brokers Upgrades & Downgrades - 12th of April 2022 V2(+)

>>> Up
* Alior Raised to Buy at Wood & Company; PT 57.70 zloty (+)
* ASMI Raised to Overweight at Barclays; PT 425 euros
* Bank of Ireland Raised to Buy at Berenberg; PT 7.50 euros
* Korian PT Raised to 40 euros from 35 euros at Bryan Garnier (+)
* Legrand Raised to Buy at SocGen; PT 95 euros
* Leonardo Raised to Buy at Deutsche Bank; PT 12 euros
* Mortgage Advice Bureau Raised to Buy at Peel Hunt
* Neste Raised to Overweight at JPMorgan; PT 53 euros
* Osai Automation System Raised to Buy at Banca Akros (+)
* Pekao Raised to Overweight at Morgan Stanley; PT 144 zloty
* Salzgitter Raised to Neutral at Oddo BHF (+)
* Unibail Raised to Neutral at Citi (+)

>>> Down
* BioMerieux Cut to Neutral at Oddo BHF; PT 108 euros (+)
* Elior Group Cut to Add at AlphaValue/Baader
* Greenvolt Cut to Neutral at JB Capital Markets; PT 7.20 euros (+)
* Investec Cut to Neutral at Goldman; PT 535 pence (+)
* LSE Cut to Neutral at Exane; PT 8,600 pence
* OTP Bank Cut to Equal-Weight at Morgan Stanley; PT 13,600 forint
* Piraeus Financial Holdings Cut to Underweight at Morgan Stanley
* PKO Cut to Equal-Weight at Morgan Stanley; PT 49 zloty
* Rapala VMC Cut to Accumulate at Inderes; PT 8.20 euros
* Rolls-Royce Cut to Underweight at JPMorgan; PT 75 pence
* SSAB Cut to Underperform at Oddo BHF (+)
* Safestore Cut to Hold at HSBC; PT 1,515 pence
* Salmar Cut to Hold at DNB Markets; PT 743 kroner
* Seaway 7 Cut to Neutral at SpareBank; PT 10 kroner
* STMicroelectronics Cut to Equal-Weight at Barclays; PT 38 euros
* Vantage Towers Cut to Neutral at New Street Research

>>> Initiation
* BiVictriX Therapeutics Rated New Buy at Panmure Gordon (+)
* De' Longhi Rated New Buy at Bestinver; PT 31 euros (+)
* Eurazeo SE Rated New Neutral at Goldman; PT 92 euros
* Intermediate Capital Rated New Buy at Goldman; PT 2,480 pence
* Partners Group Rated New Buy at Goldman; PT 1,630 Swiss francs
* Tele2 Resumed Equal-Weight at Morgan Stanley; PT 145 kronor
* Valmet Resumed Equal-Weight at Morgan Stanley

>>> Call
* Adidas PT, Estimates Cut at Morgan Stanley on China Challenges (+)
* Ferrari Raised at BNP Paribas Ahead of New BEV Strategy, Outlook
* Givaudan 1Q May Provide ‘Modest’ Support For Shares: Jefferies
* Leonardo Upgraded, BAE PT Raised on Defense Spend: Deutsche Bank (+)
* LSE Cut at Exane BNP Paribas on Top-Line Growth Uncertainty (+)
* Novo Nordisk Raised on Wegovy Relaunch Momentum: Morgan Stanley
* Plus500 Has Another Excellent Quarter, Momentum Strong: Liberum (+)
* Rolls-Royce Cut at JPMorgan on Lower Margins, New Unit Risks (+)
* Sika Delivers Solid Revenue Beat at 1Q, Morgan Stanley Says
* Valmet Equal-Weight at Morgan Stanley With Risk Skew Balanced
* Wienerberger 1Q is Strong Beat, Shares Are Cheap: Morgan Stanley (+)

Gatestone Institute : China Taking Over Africa: 'China's Second Continent'